Baird Downgrades Doximity to Neutral, Lowers Price Target to $18

Benzinga Newsdesk www.benzinga.com Negative 81.7%

Neg 81.7% Neu 0% Pos 0%

Baird analyst Vikram Kesavabhotla downgrades Doximity (NYSE:DOCS) from Outperform to Neutral and lowers the price target from $40 to $18.